Marrone Bio Innovations, Inc. Reports 2016 First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Piper Jaffray Cuts Price Target on Marine Bio (MBII) Following 1Q Report
May 13, 2016 7:58 AM EDTPiper Jaffray maintained an Overweight rating on Marrone Bio Innovations (NASDAQ: MBII), and cut the price target to $1.00 (from $2.00), following the company's 1Q earnings report. Marrone again beat Piper's top line expectations in the March ending quarter as sales growth in the specialty crop market continues to be stronger than expected, more than... More
Marine Bio (MBII) Misses Q1 EPS by 11c
May 12, 2016 4:57 PM EDTMarine Bio (NASDAQ: MBII) reported Q1 EPS of ($0.38), $0.11 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $3.05 million.
For earnings history and earnings-related data on Marine Bio (MBII) click here.
... More